1. Home
  2. LOAN vs NRSN Comparison

LOAN vs NRSN Comparison

Compare LOAN & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LOAN
  • NRSN
  • Stock Information
  • Founded
  • LOAN 1989
  • NRSN 2017
  • Country
  • LOAN United States
  • NRSN Israel
  • Employees
  • LOAN N/A
  • NRSN 15
  • Industry
  • LOAN Real Estate Investment Trusts
  • NRSN Biotechnology: Pharmaceutical Preparations
  • Sector
  • LOAN Real Estate
  • NRSN Health Care
  • Exchange
  • LOAN Nasdaq
  • NRSN Nasdaq
  • Market Cap
  • LOAN 58.1M
  • NRSN 58.8M
  • IPO Year
  • LOAN 1999
  • NRSN 2021
  • Fundamental
  • Price
  • LOAN $5.20
  • NRSN $2.35
  • Analyst Decision
  • LOAN
  • NRSN Buy
  • Analyst Count
  • LOAN 0
  • NRSN 2
  • Target Price
  • LOAN N/A
  • NRSN $14.00
  • AVG Volume (30 Days)
  • LOAN 13.6K
  • NRSN 408.0K
  • Earning Date
  • LOAN 07-21-2025
  • NRSN 07-01-2025
  • Dividend Yield
  • LOAN 8.79%
  • NRSN N/A
  • EPS Growth
  • LOAN N/A
  • NRSN N/A
  • EPS
  • LOAN 0.48
  • NRSN N/A
  • Revenue
  • LOAN $7,291,468.00
  • NRSN N/A
  • Revenue This Year
  • LOAN N/A
  • NRSN N/A
  • Revenue Next Year
  • LOAN $4.41
  • NRSN N/A
  • P/E Ratio
  • LOAN $10.90
  • NRSN N/A
  • Revenue Growth
  • LOAN N/A
  • NRSN N/A
  • 52 Week Low
  • LOAN $4.74
  • NRSN $0.51
  • 52 Week High
  • LOAN $6.05
  • NRSN $2.60
  • Technical
  • Relative Strength Index (RSI)
  • LOAN 50.76
  • NRSN 71.85
  • Support Level
  • LOAN $5.13
  • NRSN $1.90
  • Resistance Level
  • LOAN $5.20
  • NRSN $2.60
  • Average True Range (ATR)
  • LOAN 0.10
  • NRSN 0.21
  • MACD
  • LOAN 0.01
  • NRSN 0.03
  • Stochastic Oscillator
  • LOAN 47.93
  • NRSN 75.49

About LOAN Manhattan Bridge Capital Inc

Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Share on Social Networks: